Peyman Hosseinchi

Peyman Hosseinchi

Senior Associate atJDRF T1D FundMassachusetts

Peyman Hosseinchi joined the T1D Fund in February 2026, bringing experience in biotech company creation and investing. He previously worked at Raven Venture and RA Capital Management's TechAtlas division, and holds a PhD from the University of Chicago.

What Peyman can write

Writes checks ofNot reported
Comes in atSeed, Series A, Series BMostly follows a lead
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Career

  1. RA Capital Management · Associate
  2. Raven Venture
  3. RAVen (RA Ventures) · Senior Associate
  4. JDRF T1D Fund · Senior Associate
    Now

Companies founded

Stylus Medicine

Focus

biotech company creationearly-stage therapeutic strategy

Education

University of Chicago, PhD in Molecular EngineeringSharif University of Technology, dual B.S. in Mechanical & Aerospace Engineering

Also at JDRF T1D Fund

Partners like Peyman

At firms with a similar stage, sector and check size.

Alert me when JDRF T1D Fund is active

One email when Peyman's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Peyman Hosseinchi?

Peyman Hosseinchi joined the T1D Fund in February 2026, bringing experience in biotech company creation and investing. He previously worked at Raven Venture and RA Capital Management's TechAtlas division, and holds a PhD from the University of Chicago.

How much does Peyman Hosseinchi invest?

JDRF T1D Fund has not reported a check size. It invests at seed, series a, series b.

How do I pitch Peyman Hosseinchi?

A warm intro from a founder JDRF T1D Fund backed works best.

What did Peyman Hosseinchi do before JDRF T1D Fund?

Associate at RA Capital Management; Raven Venture; Senior Associate at RAVen (RA Ventures).

Last updated 2026-10-15. Is this you? Ask for a correction.